New hope for tough prostate cancer: drug trial launches
Disease control
Not yet recruiting
This study tests a daily pill called zanzalintinib in 30 men with an aggressive form of prostate cancer that has spread. The goal is to see if the drug can slow or stop the cancer from growing. Participants will take the drug until it stops working or side effects become too seve…
Phase: PHASE2 • Sponsor: Deepak Kilari • Aim: Disease control
Last updated May 07, 2026 12:47 UTC